同济医学院各单位：
2015年国际青年学者东湖论坛—转化医学分论坛定于6月26日在同济医学院召开。届时，来自国外知名大学和科研机构的40余名青年学者将应邀出席论坛并做专题报告，欢迎各位老师和同学积极参加。
时间：6月26日8:30～18:30
论坛议程：

时间	内容	地点
08:30-08:45	与会人员合影	二号教学楼正门
08:45-09:15	论坛开幕式	二号教学楼4楼1会议室
09:15-10:35	特邀报告	二号教学楼4楼1会议室
10:35-10:50	茶歇
10:50-12:20	论坛专题报告（一会场）	二号教学楼4楼1会议室
	论坛专题报告（二会场）	二号教学楼4楼2会议室
12:30-14:30	午餐、午休
14:30-18:30	论坛专题报告（一会场）	二号教学楼4楼1会议室
	论坛专题报告（二会场）	二号教学楼4楼2会议室

专题报告题目及汇报顺序如下：
Conference Room 1
Plenary Lectures
09:15-09:55 Lu Youming（鲁友明）
Tongji Medical College, HUST
09:55-10:35 Hu Bingchang（胡丙长）
Harvard Medical School,USA


Session 1

10:50-11:05	Target a Midbrain Neural Circuit for Binge Eating
11:05-11:20	From signaling networks to cancer omic analysis
11:20-11:35	Hunting for the function of Huntingtin
11:35-11:50	ZEB1: at the Crossroads of EMT, Metastasis and Therapy Resistance
11:50-12:05	Defective Crk-like protein in partial DiGeorge syndrome causes functional NK deficiency
12:05-12:20	Catalytic-independent role of DPP4 in atherosclerosis and vascular inflammation

Session 2

14:30-14:45	STAT3 depletion enhances tumor cell immunogenicity
14:45-15:00	Incipient Causes of Joint Failure
15:00-15:15	Novel dopamine signaling of dopamine D2 receptor-DISC1 protein complex contribute to antipsychotic-like effects
15:15-15:30	Characterizing the role of ubiquitin-proteasome pathways in the regulation of protein stability and tumorigenesis
15:30-15:45	Regulation of differentiation and homeostasis of Th17 cells
15:45-16:00	Artery tertiary lymphoid organs control aorta immunity and protect against atherosclerosis via vascular smooth muscle cell lymphotoxin β receptors
16:00-16:15	Cytochrome P450 epoxygenase / soluble epoxide hydrolase axis and vascular siganlling

Session 3

16:30-16:45	Posttranslational modification regulated protein communications and their impact in cancer therapy
16:45-17:00	Dissecting Epigenetic Mechanisms of Pluripotency and Reprogramming Through Interactome Studies
17:00-17:15	Role of Ca2+-activated nonselective cation channel in controlling Foxp3+ regulatory T cells suppressor function and survival
17:15-17:30	Critical roles of inflammatory ILC2 cells in infectious diseases
17:30-17:45	Pathogenic Mechanisms of TAR DNA-binding protein-43 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis
17:45-18:00	Protein Degradation Pathways in Neural Development and Degeneration
18:00-18:15	Translational study for liver carcinogenesis and developing personalized targeted treatment
18:15-18:30	Targeting DNA damage responses for glioblastoma therapy with oncolytic herpes simplex virus and molecularly targeted therapeutics

Conference Room 2
Session 1

10:50-11:05	Two miRNA Clusters, miR-34b/c and miR-449, Are Essential for Brain Development, Motile Ciliogenesis, Male and Female Fertility
11:05-11:20	Opportunities and Challenges in Total Synthesis of Natural Product for Drug Discovery
11:20-11:35	ASPP2: From cell polarity to cell plasticity - implications in tumour metastasis
11:35-11:50	Hibernating Malaria
11:50-12:05	Upconversion luminescence for bioimaging
12:05-12:20	Functional nanomaterials as drug/gene carriers for cancer therapy

Session 2

14:30-14:45	Suppression of Endometriosis by Interrupting Crosstalk between the Endometriotic Lesion and the Host Immune System
14:45-15:00	Total syntheses of small molecule natural products withpotent neurotrophic activity and anticancer activity
15:00-15:15	Phospholipid Dysregulation Contributes to ApoE4-induced Cognitive Deficits in Alzheimer’s Disease Pathogenesis
15:15-15:30	Design of D-peptide for Molecularly Targeted Therapy and Targeted Drug Delivery
15:30-15:45	Yolk-shell Structured UCNP@Silica Nanomaterials and Ultra-small Silica-polymer Hybrid Nanoparticles for Cancer Therapy
15:45-16:00	A Novel Plasma Membrane Patch for Treatment of Myocardial Infarction in Multiple Animal Models
16:00-16:15	Immunotherapy for Liver Cancer

Session 3

16:30-16:45	Ganciclovir-induced Chain Termination Revealed by Resistant Viral Polymerase Mutants With Reduced Exonuclease Activity
16:45-17:00	Construction of Intellegient Nano-scale Drug Delivery Systems Based on Fe3O4 Magnetic and Mesoporous Silica Nanoparticles for Cancer Therapy In Vitro and In Vivo
17:00-17:15	Novel mechanisms for regulating Wnt activity
17:15-17:30	Molecular Characterization and Target Therapy for Xp11 Translocation Renal Cell Carcinoma
17:30-17:45	Novel Small Molecule Modulators of the Toll-Like Receptor Complexes as Potent Vaccine Adjuvants and Anti-inflammatory Agents
17:45-18:00	A Hippo-independent pathway modulates YAP-induced resistance of cancer cells to antitubulin drugs
18:00-18:15	Investigation and Applications of Upconversion Nanomaterials: Toxicity, Blood Pool Imaging, and Detection of Biomolecules